ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Nuclear Nonproliferation Policy
The mission of the Nuclear Nonproliferation Policy Division (NNPD) is to promote the peaceful use of nuclear technology while simultaneously preventing the diversion and misuse of nuclear material and technology through appropriate safeguards and security, and promotion of nuclear nonproliferation policies. To achieve this mission, the objectives of the NNPD are to: Promote policy that discourages the proliferation of nuclear technology and material to inappropriate entities. Provide information to ANS members, the technical community at large, opinion leaders, and decision makers to improve their understanding of nuclear nonproliferation issues. Become a recognized technical resource on nuclear nonproliferation, safeguards, and security issues. Serve as the integration and coordination body for nuclear nonproliferation activities for the ANS. Work cooperatively with other ANS divisions to achieve these objective nonproliferation policies.
Meeting Spotlight
ANS Student Conference 2025
April 3–5, 2025
Albuquerque, NM|The University of New Mexico
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Apr 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
May 2025
Nuclear Technology
April 2025
Fusion Science and Technology
Latest News
First astatine-labeled compound shipped in the U.S.
The Department of Energy’s National Isotope Development Center (NIDC) on March 31 announced the successful long-distance shipment in the United States of a biologically active compound labeled with the medical radioisotope astatine-211 (At-211). Because previous shipments have included only the “bare” isotope, the NIDC has described the development as “unleashing medical innovation.”
Jorge H. Barón, Jorge E. Núñez McLeod, Selva S. Rivera
Nuclear Technology | Volume 134 | Number 2 | May 2001 | Pages 97-109
Technical Paper | Reactor Safety | doi.org/10.13182/NT01-A3189
Articles are hosted by Taylor and Francis Online.
Construction of the CAREM-25 full-size prototype, a very low power nuclear power station [25 MW(electric)], is scheduled to begin in Argentina in 2001. The CAREM-25 is designed based on principles of inherent safety, passive safety functions, and ease of operation. This paper analyzes the safety philosophy from the point of view of risk by performing a level-III probabilistic safety assessment (PSA) of this prototype. The specific PSA steps are discussed, including a specially developed method to obtain representative initiating events, system analysis by fault trees, event development in event trees, plant and containment response analysis, containment event tree development, consequence calculations, and risk representation. The PSA results are presented and discussed in terms of their own values as well as in comparison to other PSA results performed for larger nuclear power plants (NPPs). The advantages of the CAREM-25 from the risk point of view are studied in terms of the effective reduction of both the probability of severe accident sequences and the potential consequences of such sequences (radiological and emergency preparedness impact). The risk point of view also provides a perspective to analyze the impact of several design modifications in order to further reduce the residual risk of the NPP. These design modifications, several of which have already been included in the prototype, are discussed and evaluated.